Erratum: The top prescription drugs of 2009-2012 (ACS Chemical Neuroscience (2009) 1:6 (407-408) DOI:10.1021/cn1000556);The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing

ACS Chemical Neuroscience

Volumn 1, Issue 6, 2010, Pages 407-408

  Lindsley, Craig W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATORVASTATIN; CLOZAPINE; DULOXETINE; ESCITALOPRAM; NEUROLEPTIC AGENT; OLANZAPINE; OXYCODONE; QUETIAPINE; VENLAFAXINE;

CENTRAL NERVOUS SYSTEM; DRUG INHIBITION; DRUG STRUCTURE; EDITORIAL; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; PAIN; PRESCRIPTION; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 77953657570     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn400178w     Document Type: Erratum

References (9)

1. Bartholow, M. (2010) Top prescription drugs of 2009. Pharmacy Times, May 2010 (www.pharmacytimes.com/issue/pharmacy/2010/May2010/RxFocusTopDrugs-0510).
2. IMS Health (April 1, 2010). www.imshealth.com
3. Casey, D. E. (1996) Seroquel (quetiapine): preclinical and clinical findings of a new antipsychotic Exp. Opin. Invest. Drugs 5 (8) 939-957 for more information see: www.astrazenca-us.com
4. Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., and Mailman, R. (2003) Neuropsychopharmacology 28 (8) 1400-1411 for more information see: www.bms.com
5. Tamminga, C. A. and Kane, J. M. (1997) Olanzapine (Zyprexa): Characteristics of a new antipsychotic Exp. Opin. Invest. Drugs 6 (11) 1743-1752 for more information see: www.lilly.com
6. Sunshine, A., Olson, N. Z., Colon, A., Rivera, J., Kaiko, R. F., Fitzmartin, R. D., Reder, R. F., and Goldenheim, P. D. (1996) Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin. Pharm. 36 (7) 595-603 for more information see: www.purduepharma.com
7. Wong, D. T., Robertson, D. W., Bymaster, F. P., Krushinski, J. H., and Reid, L. R. (1998) LY227942, an inhibitor of serotonin and norepinephrine uptake: Biochemical pharmacology of a potential antidepressant drug Life Sci. 43 (24) 2049-2057 for more information see: www.lilly.com
8. Yardley, J. P., Husbands, G. E. M., Stack, G., Butch, J., Bicksler, J., Moyer, J. A., Muth, E. A., Andree, T., Fletcher, H., III, James, M. N. G., and Sielecki, A. R. (1990) 2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity J. Med. Chem. 33 (10) 2899-905 for more information see: www.pfizer.com
9. Chen, F., Larsen, M. B., Sanchez, C., and Wiborg, O. (2005) The S-enantiomer of R,S-citalopram increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors Eur. Neuropsychopharmacol. 15 (2) 193-198 for more information see: www.frx.com